Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating
Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating
高盛将insmed的目标股价从74美元上调至102美元,仍为买入评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册